To assess the effectiveness of shorter MDR Regimen in tertiary care centre in Western UP

Background: In an attempt to reduce the length of conventional MDR TB regimen for 18months or more WHO updated its treatment guidelines in May 2016and included a recommendation on the use of Standardised Shorter MDR TB regimen with seven drugs and a treatment duration of 9to 12 months. The study explored the experience of the programmatic management of tuberculosis on a shorter injectable containing MDRTB regimen in a tertiary care centre in western Uttar Pradesh, India. Materials and Methods: Retrospective analysis of the data in a tertiary care centre in western up was carried out. The following attributes were included in outcome analysis: 1) Cured, 2) Treatment completed, 3) Treatment failure, Treatment regimen changed, 4) Died, 5) Lost to follow up. Results: Out of 87cases 43 are Male and 44 are female. Out Of the 87cases, 15 Cases were Cured ,57 Cases Treatment Completed, in 7 Patient treatment is changed or treatment is failed, 7 patients died in which 3 patients are female and 4 patients are male and 1 lost to follow up.